FDA
-
-
-
-
-
-
-
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
-
-
-
-
-
-
-
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
-
-
-
-
-
-
323,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

